Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Metabolic Syndrome Article
This is a selection made from among articles on Drug Treatment Metabolic Syndrome. For a permanent link to this article, or to bookmark it for future reading, click here.
Effective Alcohol and Drug Treatment
from:by Morgan Hamilton
Alcohol and drug treatment has evolved quite a bit of past few decades. The first forms of alcohol and drug treatment were actually quite primitive compared to what's available today. In the dark ages it was thought that addictions were caused by demonic possession, which had many different prescribed ‘cures’ ranging from blood letting to being burned at the stake. In the 19th and early 20th century, alcohol and drug treatment had made some strides towards improvements as opposed to when addictions were then considered forms of insanity and the treatments of choice involved straight jackets, padded rooms, and electric shocks. Could you imagine? You have to wonder what they were thinking?What we consider today as modern alcohol and drug treatment didn’t really start until the second half of the 20th century. This was no doubt one of the well-known and often repeated ’12 step’ program designed by Alcoholics Anonymous. Doctors and practitioners slowly came to realize that effective alcohol and drug treatment was in fact a possibility. Some of the first forms of alcohol and drug treatment centers formed in this time were not much more than centers where the 12 step program could be taught. The treatments were actually more psychological than anything else. Even well into the 1980’s handing someone a ‘big book’ (the Alcoholics Anonymous guide) and telling them to go to 90 meetings in 90 days was a common and acceptable form of alcohol and drug treatment. We have made great strides from then in our understanding of what does and what does not work as far as drug and alcohol treatment is concerned. Please don't misunderstand me, the 12 step program can be effective for some individuals. One often really wonderful things about it is that it is for a show anyone who needs to help can take advantage of, there are no economic barriers. There is no reason to pay exorbitant fees for alcohol and drug treatment only to get a copy of the big book and a list of nearby meetings. Finding listings for meetings in your area is as simple as calling on the Internet or looking through a phone book. This doesn’t mean that alcohol and drug abuse treatment isn’t necessary. The treatment should be seen as a supplement to two other programs and not relied upon as a stand-alone solution. When you do decide to seek alcohol and drug abuse treatment be sure that you select one that is known for providing services beyond just 12 step model functions. I myself am a counselor and a recovering addict from my experience I can say with some confidence that the most effective way to help yourself in recovery is to try out many different forms of alcohol and drug treatment, don't limit yourself because we are all different. If you follow this advice you are sure to find at least some methods that will be effective for you.
Morgan Hamilton offers his findings and insights regarding health and medicine. You can get interesting information here at Alcohol and Drug Treatment
Drug Treatment Metabolic Syndrome Specific links
Drug Treatment Metabolic Syndrome News
Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of ...
Baxter International Inc. today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids .
Read more...Spherix Announces First Quarter 2012 Financial Results
BETHESDA, Md. -- Spherix Incorporated -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, ...
Read more...Corcept Therapeutics Announces First Quarter Results and Corporate and Development Update
MENLO PARK, CA-- - Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic and psychiatric ...
Read more...Catalyst Pharmaceutical Partners Reports Positive Results From Phase I(a) Clinical Study of CPP-115
CORAL GABLES, Fla. -- Catalyst Pharmaceutical Partners, Inc. today announced positive results from a Phase I(a) study to evaluate the safety, tolerability and pharmacokinetic (PK) profile of CPP-115, a ...
Read more...Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of ...
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved an expanded dose range for LATUDA in the treatment of adult patients with schizophrenia.
Read more...Farmington Hills Clinic Fighting Alzheimer’s, Parkinson’s
Clinical studies under way now at the Michigan Institute of Neurological Disorders and the Quest Research Institute may lead to improved treatments for Alzheimer's and Parkinson's diseases.
Read more...Press Release
Sunovion Pharmaceuticals Inc. Posted on:05 May 12 Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded dose range for LATUDA in the treatment of adult patients with schizophrenia.
Read more...Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
CARLSBAD, Calif., May 4, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (ISIS) announced the initiation of a Phase 2 study evaluating ISIS-APOCIIIRx in patients with hypertriglyceridemia. Hypertriglyceridemia, ...
Read more...Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic ...
RARITAN, N.J., May 17, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release tablets were ...
Read more...Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase ...
Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression .
Read more...